AstraZeneca vaccine safe to use while potential rare effects probed: WHO

GENEVA (Reuters) - The AstraZeneca COVID-19 vaccine is still recommended for use while studies continue to examine any potential link to "very rare" side effects including blood clots, a senior World Health Organization (WHO) official said on Friday.

"The position stands that the benefits outweigh the risks," Mariangela Simao, WHO assistant director-general, told a news conference. "It's being investigated, a potential link to a very rare side-event...which would happen (to) one in a million, is still being investigated by WHO and also by the European Medicines Agency and other regulatory agencies."

(Reporting by Stephanie Nebehay and Emma Farge; editing by Brenna Hughes-Neghaiwi)

You May Also Be Interested In

• Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
• Intuit issues conservative full-year guidance amid strategy shift, shares slide
• Truflation sees July core PCE at 0.2% MoM, says Fed won’t hike this year